Testing Market size is USD 2.24 Billion in 2025 and is expected to reach USD 6.66 Billion by 2035 due to the increasing adoption of NIPTAustin, March 10, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, ...

As hopeful parents start their reproductive journeys, they may be offered a variety of tests and screenings, which can be opportunities to learn more about their own health ...

Abstract: Non-Invasive Prenatal Testing (NIPT) is an advanced screening method for fetal chromosomal abnormalities, holding significant importance in prenatal risk diagnosis. To optimize the grouping ...

Non-invasive prenatal testing (NIPT) has recently expanded to include sex chromosomal aneuploidies (SCAs) and copy number variations (CNVs), as well as the commonly screened trisomies (T21, T18, and ...

Abstract: Down syndrome, induced by trisomy 21 (T21), manifests as cognitive impairment and significant fetal congenital anomalies. Noninvasive prenatal testing (NIPT) for trisomy 21 involves the ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...

Objectives Despite the increasing availability of non-invasive prenatal testing (NIPT), women’s experiences and motivations remain largely unknown. The use of NIPT is increasing in Italy; however, its ...

This Research Topic presents a curated collection of seven articles highlighting recent advances in prenatal diagnosis, fetal medicine, and perinatal outcomes. The articles span a spectrum of ...